G
Green Biologics
Renewable chemicals naturally designed to deliver the performance that adds value to everyday products
About Green Biologics
Biocleave specializes in the production of high-purity, active recombinant proteins using non-pathogenic clostridia as an endotoxin-free expression host. The company operates in the biotechnology sector, serving clients in the pharmaceutical, research, and industrial biotechnology markets. Biocleave's business model revolves around leveraging its extensive strain collection and over 15 years of expertise in engineering, adapting, and fermenting clostridia to push the boundaries of protein expression. By utilizing endogenous CRISPR Cas technology, Biocleave is able to engineer these microbes for novel applications, providing a unique value proposition to its clients. The company generates revenue through the sale of its recombinant proteins and related services, catering to scientists and researchers who require high-quality, endotoxin-free proteins for their work.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Employees
- 26
- Open positions
- None listed
- Industry
- Energy, Chemicals
- Sub-industry
- Clean Energy
- Sector
- Biotechnology, Chemistry, Synthetic Biology, Sustainable Development Goals, Climate Tech, Hard Tech, uk is8 digital and technologies
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Oct 2020 | — | — | Undisclosed | — |
| GRANTOther financing | Apr 2018 | $436K | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Green Biologics is 290 monthly website visits, down 12.1% over the last three months. Green Biologics's team declined 10.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
ShellworksCompostable, microbe-derived packaging for the beauty industry |
London, United Kingdom | Operational | 46 | $24M | $60M |
PuraffinityEngineered adsorbent media for targeted PFAS water purification. |
London, United Kingdom | Operational | |||
BactobioLondon-based biotechnology company using breakthrough technologies in synthetic biology |
London, United Kingdom | Operational | |||
Deep Blue BiotechCarbon-negative specialty chemicals using engineered cyanobacteria |
London, United Kingdom | Operational | |||
HERlabAI platform for discovery of new yeast strains for precision fermentation |
London, United Kingdom | Operational | |||
MultusAI-driven growth media for cellular agriculture. |
London, United Kingdom | Operational | |||
ColorifixBiological textile dyeing process using engineered microbes |
Norwich, United Kingdom | Operational | |||
TropicGene-editing platform for climate-resilient tropical crop varieties |
Norwich, United Kingdom | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Green Biologics in the Abingdon ecosystem
The Green Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Oxford Capital
Carbon Trust
Capricorn Partners
Morningside Venture Partners- 3P350 Investment Partners
Rockley Ventures
Morningside
Sofinnova Partners
Series B and later2 investors entered at this stage
Swire Pacific
Swire.
Other known investors4 additional known investors
BloombergNEF
Longwall Ventures- TPTennenbaum Capital Partners
Wren Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Green Biologics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Green Biologics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










